Emergent BioSolutions Reports First Quarter 2017 Financial Results; Reaffirms 2017 Guidance
Go back to Emergent BioSolutions Reports First Quarter 2017 Financial Results; Reaffirms 2017 Guidance| EMERGENT BIOSOLUTIONS, Inc. (NYSE: EBS) | Delayed: 6.55 -0.25 (3.68%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.80 | 52 Week High | $44.38 | |||
| Open | $6.80 | 52 Week Low | $24.47 | |||
| Day High | $6.90 | P/E | 327.50 | |||
| Day Low | $6.48 | EPS | $0.02 | |||
| Volume | 1,512,574 | |||||
